Concord Drugs Financials

BSE: 538965

₹80.90

₹1.22 (1.53%)

As on 10-Sep-2026IST

Market cap

₹107 Cr

Revenue (TTM)

₹86 Cr

P/E Ratio

52.3

P/B Ratio

2.2

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	86.11	45.24	44.92	52.08	58.96	--
Total Income	86.11	45.26	44.93	52.09	59.06	--
Total Expenditure	80.29	41.11	40.88	47.51	53.36	--
EBITDA	5.83	4.13	4.04	4.57	5.59	--
Depreciation	1.35	1.43	1.56	1.63	1.76	--
EBIT	4.48	2.70	2.49	2.95	3.83	--
Interest	1.62	2.03	1.87	1.71	1.68	--
Other Income	--	0.01	0.01	0.01	0.10	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	2.86	0.69	0.63	1.25	2.25	--
Provision for Tax	0.81	0.36	0.16	0.26	0.65	--
Profit after Tax	2.05	0.34	0.47	0.99	1.59	--
Minority Interest	--	--	--	--	--	--
Share of Associate	--	--	--	--	--	--
Consolidated Profit	2.05	0.34	0.47	0.99	1.59	--

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	48.51	34.11	33.82	31.70	28.36	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	5.31	4.85	3.98	4.91	4.44	--
Current Liabilities	21.07	26.18	21.00	21.62	23.65	--
Total Liabilities	74.89	65.14	58.81	58.23	56.45	--

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	14.87	24.38	21.29	14.77	14.55	--
Current Assets	53.31	40.76	37.52	43.46	41.89	--
Total Assets	74.89	65.14	58.81	58.23	56.45	--
Total Debt*	--	19.24	17.52	16.97	16.43	--
Net Current Assets	32.25	14.58	16.51	21.84	18.24	--
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	--	3.72	0.79	1.66	0.77	--
Cash Flow from Investing Activities	--	-2.32	-1.01	-2.27	-2.44	--
Cash from Financing Activities	--	-1.43	0.28	0.62	1.68	--
Net Cash Inflow / Outflow	--	-0.02	0.07	0.02	0.01	--

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	1.78	0.34	0.47	1.06	1.82	--
Cash EPS (₹)	1.56	1.77	2.03	2.80	3.84	--
Adjusted Book Value (₹)	37.67	34.11	33.82	33.43	32.44	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	3.72	0.79	1.79	0.89	--
Free Cash Flow per Share (₹)	--	-0.78	-2.02	-0.75	-3.51	--

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	--	5.19	4.99	6.32	8.77	--
ROE (%)	4.94	0.99	1.45	3.31	5.62	--
ROA (%)	2.93	0.54	0.81	1.72	2.82	--
EBIT Margin (%)	5.20	5.98	5.54	5.66	6.49	--
Net Margin (%)	2.38	0.74	1.05	1.89	2.70	--
Cash Profit Margin (%)	--	3.91	4.51	5.01	5.70	--

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	82.54	0.71	-13.74	-11.66	--	--
EBIT Growth (%)	55.90	8.70	-15.58	-23.04	--	--
Net Profit Growth (%)	413.10	-28.83	-52.06	-38.19	--	--
EPS Growth (%)	301.16	-28.83	-55.35	-41.98	--	--
Book Value Growth (%)	--	0.88	8.60	9.80	--	--

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	52.35	92.45	74.45	25.95	15.90	--
Price / Book Value	2.16	0.91	1.04	0.82	0.89	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	20.63	12.08	12.96	9.26	7.33	--
Close Price (₹)	75.64	31.08	35.17	27.45	29.00	--
High Price (₹)	92.52	44.96	61.50	41.65	44.95	--
Low Price (₹)	42.30	26.10	25.56	19.50	24.80	--
Market Cap (₹ Cr)	107.36	31.08	35.17	25.57	25.36	--

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	0.04	0.56	0.52	0.54	0.58	--
Short term debt to equity ratio	--	0.47	0.47	0.45	0.49	--
Current Ratio	2.53	1.56	1.79	2.01	1.77	--
Quick Ratio	1.32	0.59	0.69	1.08	1.03	--
Interest Coverage	2.76	1.34	1.34	1.73	2.34	--

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	28.31	30.07	28.34	30.36	38.77	--
Asset Turnover	1.23	0.73	0.77	0.91	1.04	--
Receivable days	--	106.22	115.94	135.50	141.52	--
Inventory Days	--	194.39	174.63	131.60	108.28	--
Payable days	--	67.34	56.60	78.03	96.87	--
Cash Conversion Cycle	--	233.27	233.97	189.07	152.93	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.